State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...

Shares of Globus Medical, Inc. (NYSE:GMED – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve research firms that are presently covering the firm ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical's advisors include Morgan Stanley & Co. LLC and Wyrick Robbins Yates & Ponton LLP; Nevro's advisors are BofA Securities, Inc. and Latham & Watkins LLP. Disclaimer: This is an AI ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

A Florida federal judge has issued a report and recommended that a sales representative pay more than $19 million to resolve ...

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.